PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Coverage · Medical Policy · Dermatology, Plastic Surgery, General SurgeryMedium impact

MA11.071b, Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)

Effective date
Apr 1, 2026
Identified
Jun 19, 2026

Summary

Independence Blue Cross reissued MA11.071b on 04/01/2026 to reaffirm its coverage position on selective photothermolysis using pulsed-dye lasers (PDL). The policy clarifies that PDL treatment for psoriasis, molluscum contagiosum, basal cell carcinoma, cutaneous lupus erythematosus, and cutaneous sarcoidosis remains experimental/investigational and non-covered. The policy also updated criteria for rosacea treatment to align with current clinical standards and added specific ICD-10 diagnosis codes for non-covered indications.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01By 04/01/2026: Billing team must update claim edits in billing software to automatically deny or flag for prior authorization review any PDL claims (CPT 17000, 17003, 17004, 17106, 17107) with ICD-10 diagnosis codes B08.1, C44.01, C44.111, C44.1121, C44.1122, C44.1191, C44.1192, C44.211, C44.212, C44.219, C44.310, C44.311, C44.319, C44.41, C44.510, C44.511, C44.519, C44.611, C44.612, C44.619, C44.711, C44.712, C44.719, C44.81, C44.91, D86.3, L40.0, L40.8, L40.9, or L93.1 (experimental/investigational indications).
02Verify that rosacea treatment claims (L71.1, L71.8, L71.9) include documentation of clinically significant rosacea stage and failed medical management with at least six months of conventional treatment.
03Update provider communications and encounter forms to reflect that cosmetic indications (striae distensae, cherry hemangiomas, spider angiomas, telangiectasia without rosacea, wrinkles) are non-covered.
04Claims submitted for these excluded conditions will be denied.

Codes mentioned

1700017003170041710617107B08.1C44.01C44.111C44.1121C44.1122C44.1191C44.1192C44.211C44.212C44.219C44.310C44.311C44.319C44.41C44.510C44.511C44.519C44.611C44.612C44.619C44.711C44.712C44.719C44.81C44.91D86.3L40.0L40.8L40.9L93.1A63.0B07.0B07.8B07.9D18.01D18.09L92.8L98.0L91.0L71.1L71.8L71.9L90.5Q82.5

Original notice

MA11.071b, Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account